Could your own immune cells stop colon cancer returning?
NCT ID NCT05394714
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial tests a new treatment called Magicell-NK for people with stage I or IIa colon cancer who have already had surgery to remove the tumor. The treatment uses a patient's own natural killer (NK) cells, which are grown and activated in a lab and then infused back into the body. The main goal is to check safety and find the best dose, with 18 participants receiving one of three dose levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magicell-NK (a patient's own natural killer cells grown and activated in a lab)
What this could lead to
If it works, this could point toward a treatment to prevent colon cancer from coming back after surgery without needing chemotherapy.
What could go wrong
This is a very early, small Phase 1 trial with only 18 people, focused on safety. It may not show any benefit, and side effects like infusion reactions or immune overactivation are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Linkou
RECRUITINGTaoyuan, 333, Taiwan
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact